Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism

Updated on: April 03,2025 0

Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism

Updated on:April 03,2025 0

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P

Updated on: August 26,2024 0

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P

Updated on:August 26,2024 0

Research reveals link between spinal muscular atrophy and liver damage

byAgency for Science, Technology and Research (A*STAR), SingaporeGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI173702An international study has

Updated on: July 31,2024 0

Research reveals link between spinal muscular atrophy and liver damage

byAgency for Science, Technology and Research (A*STAR), SingaporeGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI173702An international study has

Updated on:July 31,2024 0

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress

Updated on: July 11,2024 0

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress

Updated on:July 11,2024 0

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh

Updated on: July 17,2024 0

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh

Updated on:July 17,2024 0

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on: June 20,2024 8

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on:June 20,2024 8

Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

by Joel Adriano, SciDev.NetA microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and PreventionCountries in Asia Pacific are unlikely to meet their commitment to elimi

Updated on: July 08,2024 0

Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

by Joel Adriano, SciDev.NetA microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and PreventionCountries in Asia Pacific are unlikely to meet their commitment to elimi

Updated on:July 08,2024 0

Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect

Updated on: June 25,2024 7

Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect

Updated on:June 25,2024 7

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on: June 20,2024 6

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on:June 20,2024 6

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &

Updated on: June 20,2024 5

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &

Updated on:June 20,2024 5

Alcohol-related liver disease: Mechanism could form basis for development of new therapies

by Medical University of ViennaCredit: AI-generated imageAlcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of

Updated on: June 06,2024 5

Alcohol-related liver disease: Mechanism could form basis for development of new therapies

by Medical University of ViennaCredit: AI-generated imageAlcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of

Updated on:June 06,2024 5

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno

Updated on: July 11,2024 0

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno

Updated on:July 11,2024 0